Broadwater Capital’s Edwards Lifesciences EW Stock Holding History

Broadwater Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Hold	1,200	–	–	0.08%	85
2026 Q1	$102K	Hold	1,200	–	–	0.08%	85
2025 Q4	$102K	Hold	1,200	–	–	0.08%	85
2025 Q3	$93.3K	Sell	1,200 -148,963	-99%	-$11.6M	0.07%	94
2025 Q2	$150M	Buy	150,163 +148,243	+7,721%	+$11.1M	0.12%	81
2025 Q1	$139K	Hold	1,920	–	–	0.11%	84
2024 Q4	$142K	Hold	1,920	–	–	0.11%	83
2024 Q3	$127K	Hold	1,920	–	–	0.09%	87
2024 Q2	$177K	Hold	1,920	–	–	0.14%	80
2024 Q1	$183K	Hold	1,920	–	–	0.14%	82
2023 Q4	$146K	Buy	+1,920	New	+$134K	0.11%	89

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Broadwater Capital's EW Position: Q2 2026 in Review

Broadwater Capital held its Edwards Lifesciences (EW) position steady in Q2 2026 at 1,200 shares worth $109K. The position accounts for 0.08% of the portfolio, ranked #85.

Broadwater Capital first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $150M in Q2 2025. 674 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Broadwater Capital held 1,200 shares of Edwards Lifesciences worth $109K as of Q2 2026.
Broadwater Capital left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.08% of Broadwater Capital's portfolio in Q2 2026, its #85 holding.
Broadwater Capital first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
Broadwater Capital's Edwards Lifesciences position peaked at $150M in Q2 2025.
674 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.